No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Anticoagulants / therapeutic use
-
Betacoronavirus
-
C-Reactive Protein / metabolism
-
COVID-19
-
Computed Tomography Angiography
-
Coronavirus Infections / blood*
-
Coronavirus Infections / physiopathology
-
Coronavirus Infections / therapy
-
Enoxaparin / therapeutic use
-
Female
-
Ferritins / blood
-
Fibrin Fibrinogen Degradation Products / metabolism
-
Fibrinogen / metabolism
-
Heparin / therapeutic use
-
Humans
-
Incidence
-
Intensive Care Units*
-
L-Lactate Dehydrogenase / blood
-
Male
-
Middle Aged
-
Pandemics
-
Partial Thromboplastin Time
-
Pneumonia, Viral / blood*
-
Pneumonia, Viral / physiopathology
-
Pneumonia, Viral / therapy
-
Prothrombin Time
-
Pulmonary Embolism / blood
-
Pulmonary Embolism / diagnostic imaging
-
Pulmonary Embolism / epidemiology*
-
Pulmonary Embolism / prevention & control
-
SARS-CoV-2
-
Severity of Illness Index
-
Ultrasonography
-
Venous Thromboembolism / blood
-
Venous Thromboembolism / diagnostic imaging
-
Venous Thromboembolism / epidemiology
-
Venous Thromboembolism / prevention & control
-
Venous Thrombosis / blood
-
Venous Thrombosis / diagnostic imaging
-
Venous Thrombosis / epidemiology*
-
Venous Thrombosis / prevention & control
Substances
-
Anticoagulants
-
Enoxaparin
-
Fibrin Fibrinogen Degradation Products
-
fibrin fragment D
-
Fibrinogen
-
Heparin
-
C-Reactive Protein
-
Ferritins
-
L-Lactate Dehydrogenase